These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD? Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554 [TBL] [Abstract][Full Text] [Related]
45. Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary disease. Puig A; McElligott S; Bergquist H; Doshi JA Am J Geriatr Pharmacother; 2010 Dec; 8(6):571-82. PubMed ID: 21356506 [TBL] [Abstract][Full Text] [Related]
46. Pharmacology and therapeutics of bronchodilators. Cazzola M; Page CP; Calzetta L; Matera MG Pharmacol Rev; 2012 Jul; 64(3):450-504. PubMed ID: 22611179 [TBL] [Abstract][Full Text] [Related]
47. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease. Patel M; Thomson NC Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221 [TBL] [Abstract][Full Text] [Related]
48. Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD. Moulton BC; Fryer AD Br J Pharmacol; 2011 May; 163(1):44-52. PubMed ID: 21198547 [TBL] [Abstract][Full Text] [Related]
49. Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease. Busch-Petersen J; Lainé DI Future Med Chem; 2011 Oct; 3(13):1623-34. PubMed ID: 21942252 [TBL] [Abstract][Full Text] [Related]
50. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Sin DD; Man SF Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807 [TBL] [Abstract][Full Text] [Related]
51. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease. Yao W; Wang G; Zhu H; Sun Y; Zhao M Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443 [TBL] [Abstract][Full Text] [Related]
57. The COPD Pipeline XVII. Gross N COPD; 2012 Aug; 9(4):432-4. PubMed ID: 22734623 [No Abstract] [Full Text] [Related]
58. Limitations of model based dose selection for indacaterol in patients with chronic obstructive pulmonary disease. Wang Y; Lee JY; Michele T; Chowdhury BA; Gobburu JV Int J Clin Pharmacol Ther; 2012 Sep; 50(9):622-30. PubMed ID: 22578206 [TBL] [Abstract][Full Text] [Related]
59. [Pharmacological therapy of chronic obstructive pulmonary disease]. Montuschi P Ann Ist Super Sanita; 2003; 39(4):557-72. PubMed ID: 15098576 [TBL] [Abstract][Full Text] [Related]